Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
etodolac (lodine) (3 trials)
propranolol (inderal) (3 trials)
sorafenib (nexavar) (1 trial)
Cachexia (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Prostatic Neoplasms (Phase 2)
Wasting Syndrome (Phase 2)
Trials (3 total)
Trial APIs (3 total)